AUTHOR CONTRIBUTIONS
XS, BC, and SZ designed the study. XS, CH, NH, BC, and SZ performed the experiments. XS, BC, and SZ analyzed the data, and XS wrote the paper with help from all authors.
REFERENCES
1. Cao Z, Gao W, Bao H, Feng H, Mei S, Chen P, Gao Y, Cui Z, Zhang Q, Meng X et al : VV116 versus Nirmatrelvir-Ritonavir for Oral Treatment of Covid-19 . N Engl J Med 2022.
2. COVID-19 Excess Mortality Collaborators. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21 (vol 399, pg 1513, 2022) . Lancet 2022, 399 (10334):1468-1468.
3. Abdool Karim SS, de Oliveira T:New SARS-CoV-2 Variants - Clinical, Public Health, and Vaccine Implications . N Engl J Med 2021, 384 (19):1866-1868.
4. Machhi J, Herskovitz J, Senan AM, Dutta D, Nath B, Oleynikov MD, Blomberg WR, Meigs DD, Hasan M, Patel Met al : The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections . Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2020, 15 (3):359-386.
5. Li DD, Zhang JW, Li JM:Primer design for quantitative real-time PCR for the emerging Coronavirus SARS-CoV-2 . Theranostics 2020,10 (16):7150-7162.
6. Menni C, Valdes AM, Polidori L, Antonelli M, Penamakuri S, Nogal A, Louca P, May A, Figueiredo JC, Hu Cet al : Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study . Lancet 2022,399 (10335):1618-1624.
7. Markewitz RDH, Wandinger KP, Junker R: Saliva for Detection of SARS-CoV-2 . N Engl J Med2021, 384 (9):e31.
8. Wyllie AL, Fournier J, Casanovas-Massana A, Campbell M, Tokuyama M, Vijayakumar P, Warren JL, Geng B, Muenker MC, Moore AJ et al : Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2 . N Engl J Med 2020, 383 (13):1283-1286.
9. Drain PK: Rapid Diagnostic Testing for SARS-CoV-2 . N Engl J Med 2022,386 (3):264-272.